Tennessee AG Challenges Local PSE Prescription Laws
This article was originally published in The Tan Sheet
Executive Summary
Tennessee AG Robert Cooper pushes back against local ordinances to require prescriptions for pseudoephedrine. Acura Pharmaceuticals says stricter local laws could block potential extraction-resistant products from OTC sale.
You may also be interested in...
FSA/HSA Coverage Tops CHPA 2014 Legislative Goals
The Consumer Healthcare Products Association’s No. 1 legislative priority in 2014 is restoring OTC coverage by flexible spending and health savings accounts, followed by a “close No. 2” goal of establishing an age requirement to buy DXM products. Other goals include protecting access to PSE products and blocking take-back programs.
FSA/HSA Coverage Tops CHPA 2014 Legislative Goals
The Consumer Healthcare Products Association’s No. 1 legislative priority in 2014 is restoring OTC coverage by flexible spending and health savings accounts, followed by a “close No. 2” goal of establishing an age requirement to buy DXM products. Other goals include protecting access to PSE products and blocking take-back programs.
Rx-Only Pseudoephedrine Stalls As Meth Solution In Tennessee, Indiana
Tennessee’s meth lab seizures are up this year, but CHPA says that’s because more labs are uncovered through the state’s participation in the NPLEx stop-sale system. Rx-only bills have stalled in several states, including Indiana, where lawmakers passed a bill to cap PSE purchases at about 61 grams per year.